NCT02669953View on ClinicalTrials.gov

Aflibercept in Recurrent or Persistent CNV

RecruitingOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions

Age Related Macular DegenerationIntravitreal InjectionsDiabetic Macular Edema

Interventions

DRUG

Aflibercept

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER